(Stroke. 2006;37:1546.)
© 2006 American Heart Association, Inc.
Research Reports |
From the Department of Neurology (M.R., A.H., S. Krüger, S. Kretzer, T.E.); the Department of Nuclear Medicine (J.T.); and the Department of Neuroradiology (S.Z., J.W.), University of Freiburg, Germany.
Correspondence to Andreas Hetzel, MD, Department of Neurology and Clinical Neurophysiology, University of Freiburg, Neurocenter, Breisacherstr. 64, D-79106 Freiburg, Germany. E-mail andreas.hetzel{at}uniklinik-freiburg.de
| Abstract |
|---|
|
|
|---|
Methods The study was originally undertaken to investigate by transcranial Doppler sonography, positron emission tomography and perfusion MRI whether transcranial application of wide-field low-frequency ultrasound (300 kHz) improves cerebral hemodynamics in patients with cerebral small vessel disease.
Results Showing no clear positive effect on cerebral hemodynamics in 4 patients and on cerebral perfusion (positron emission tomography) in 2 patients, the study has been terminated early because of a remarkable side effect in the first patient (a 62 year-old man) undergoing perfusion-MRI: detection of frontoparietal extravasation of Gadolinium contrast agent (applied during MRI perfusion imaging preinsonation) on MRI immediately postinsonation.
Conclusions Abnormal permeability of the human blood-brain barrier can be induced by wide-field low-frequency insonation. The observed excessive bleeding rate with low-frequency sonothrombolysis might thus be attributable to primary blood-brain barrier disruption by ultrasound.
Key Words: blood-brain barrier hemodynamic phenomena leukoaraiosis side effect ultrasound
| Introduction |
|---|
|
|
|---|
In that study, we originally aimed to investigate whether transcranial application of low-frequency ultrasound improves cerebral perfusion and hemodynamics in chronically hypoperfused brains such as of patients with cerebral small vessel disease. The investigation was stimulated by animal data showing NO-mediated flow recovery in ischemic tissue by low-frequency ultrasound.2,3
| Methods |
|---|
|
|
|---|
|
Low-frequency ultrasound was applied through the right temporal bone window using an array transducer fixed by a headband. The insonation system (NeuroFlow, Walnut Technologies, Inc) was the same used in the sonothrombolysis study.1 It consisted of an array transducer emitting low-frequency ultrasound (
300 kHz) with 700 mW/cm2 temporal average-spatial peak intensity. The transducers were arranged to cover a large bilateral target region around the basal ganglia and periventricular white matter. The peak rarefactional pressure was significantly below 1 atmosphere, thereby avoiding cavitation. The mechanical index was <0.5. The low intensity levels combined with the low frequency resulted in a thermal index soft tissue of <1.0 and a thermal index cranial of
5.0. The higher thermal index cranial was addressed through the use of heat sinking, which wicks heat away from the transducer array, and the use of a gel pad between the transducer and the skin. A thermal sensor was placed at skin level to control for excessive heating.
| Results |
|---|
|
|
|---|
|
The first and only patient undergoing MRI perfusion imaging showed abnormalities on MRI immediately after 60 minutes of insonation before reapplication of Gd-DTPA (Figure 2). These were at first sight indicative of subarachnoid hemorrhage. The patient was, however, completely asymptomatic, and cerebrospinal fluid taken shortly afterward revealed a high concentration of Gd-DTPA (18.9 mmol/L) and no erythrocytes. MRI follow-up at 2 weeks did not show any new lesions. On repetition of insonation in the same patient, the effect was not observed again, whereas perfusion analysis did not show any changes after insonation. For reasons of security it was decided to stop the study early, and no other patient underwent insonation with perfusion MRI or PET imaging.
|
| Discussion |
|---|
|
|
|---|
The present study, however, has been terminated early because of a remarkable side effect: frontoparietal extravasation of contrast agent. This passage of 0.5 kDa Gd-DTPA indicates abnormal permeability of the blood-brain barrier (BBB) after insonation. Such a phenomenon has not been directly observed in humans so far. It indicates that the observed excessive bleeding rate with low-frequency sonothrombolysis comprising also atypical locations (like the intraventricular or subarachnoid space) might in fact be attributable to primary disruption of the BBB.1
In comparison to routine 2 MHz Doppler devices (as also used in another large sonothrombolysis study without hemorrhagic side-effects4), the applied device had a wider sonification field but comparable power. Transient disruption of the BBB by focused ultrasound has been described recently in animals when applied in the presence of preformed gas bubbles.5 Furthermore, ultrastructural animal studies have, among other mechanisms, proposed endothelial injury with high power, but partly opening of tight junctions already with low-power insonation.6
A clue to the mechanism of BBB disruption in our patient might be that it occurred distant to the target volume: standing waves near the bone at the border zone of the large insonation field may have occurred during continuous insonation and lead to local heating or mechanical effects disrupting the BBB. Small-field insonation should thus be preferred for sonothrombolysis in acute ischemic stroke.
Patients with cerebral small vessel disease may well already have an impaired BBB (vascular leakage),7 and this precondition might have contributed to an increased ultrasound vulnerability in our case and also in patients experiencing hemorrhagic complications after sonothrombolysis.
Though the transient BBB disruption could also bear a therapeutic potential by facilitating drug delivery of macromolecules, it has to be tentatively regarded as a negative effect of wide-field low-frequency ultrasound on the cerebral endothelium outweighing any potential benefit on thrombolysis or cerebral perfusion.
| Acknowledgments |
|---|
Received October 22, 2005; revision received February 27, 2006; accepted February 28, 2006.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Tsivgoulis and A. Alexandrov Ultrasound-Enhanced Thrombolysis: From Bedside to Bench Stroke, May 1, 2008; 39(5): 1404 - 1405. [Full Text] [PDF] |
||||
![]() |
T. Saguchi, H. Onoue, M. Urashima, T. Ishibashi, T. Abe, and H. Furuhata Effective and Safe Conditions of Low-Frequency Transcranial Ultrasonic Thrombolysis for Acute Ischemic Stroke: Neurologic and Histologic Evaluation in a Rat Middle Cerebral Artery Stroke Model Stroke, March 1, 2008; 39(3): 1007 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wilhelm-Schwenkmezger, P. Pittermann, K. Zajonz, O. Kempski, M. Dieterich, and M. Nedelmann Therapeutic Application of 20-kHz Transcranial Ultrasound in an Embolic Middle Cerebral Artery Occlusion Model in Rats: Safety Concerns Stroke, March 1, 2007; 38(3): 1031 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reinhard, T. Els, and A. Hetzel Response to Letter by Gerriets et al Stroke, February 1, 2007; 38(2): 252 - 252. [Full Text] [PDF] |
||||
![]() |
T. Gerriets, M. Walberer, M. Nedelmann, G. Bachmann, and M. Kaps Blood-Brain Barrier Disruption by Low-Frequency Ultrasound Stroke, February 1, 2007; 38(2): 251 - 251. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |